User profiles for Melissa Daou

Melissa Daou

Brigham and Women's Hospital
Verified email at bwh.harvard.edu
Cited by 21

[HTML][HTML] Telehealth in rheumatology: the 2021 Arab league of rheumatology best practice guidelines

N Ziade, I Hmamouchi, L El Kibbi, M Daou… - Rheumatology …, 2022 - Springer
To develop Best Practice Guidelines (BPG) for the use of Telehealth in Rheumatology in the
Arab region, to identify the main barriers and facilitators of telehealth, and to provide …

Benchmarking mismatch repair testing for patients with cancer receiving immunotherapy

EB Farhat, E Adib, M Daou, EP Henske, AR Naqash… - Cancer cell, 2024 - cell.com
Mismatch repair deficiency (MMR-D) has become a theragnostic marker to guide treatment
with immune checkpoint inhibitors (ICIs) for patients at all stages of cancer and with a …

Ensuring care continuity in extreme crises: A participatory action research approach

M Daou, S Helou, J El Helou… - MEDINFO 2021: One …, 2022 - ebooks.iospress.nl
The Lebanese healthcare system has been facing major challenges due to an unprecedented
financial crisis, socio-political instability, and the COVID-19 pandemic. This study aims to …

Analysis of ASS1 gene in ten unrelated middle eastern families with citrullinemia type 1 identifies rare and novel variants

M Daou, M Souaid, T Yammine… - … Genetics & Genomic …, 2023 - Wiley Online Library
Background Citrullinemia type 1 (CTLN1) is a rare autosomal recessive disease caused by
argininosuccinate synthetase (ASS) deficiency. Manifestations vary from the acute neonatal …

[HTML][HTML] TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex

…, PM Cory, M Alchoueiry, S Salem, M Daou… - Nature …, 2024 - nature.com
Tuberous Sclerosis Complex (TSC) is caused by TSC1 or TSC2 mutations, leading to
hyperactivation of mechanistic target of rapamycin complex 1 (mTORC1) and lesions in multiple …

Virtual reality for healthcare: A scoping review of commercially available applications for head-mounted displays

S Helou, N Khalil, M Daou, E El Helou - Digital health, 2023 - journals.sagepub.com
Objective This scoping review aimed to describe the scope of commercially available virtual
reality (VR) healthcare applications for mainstream head-mounted displays (HMD)s. …

Abstract B019: Clinical and molecular characterization of chromophobe renal cell carcinoma: A focus on immunotherapy based regimens and the tumor immune …

…, N Schindler, RM Saliby, E Saad, S Salem, M Daou… - Cancer Research, 2023 - AACR
Background: Chromophobe renal cell carcinoma (ChRCC) represents 5% of all kidney
cancers. In contrast to clear cell RCC (ccRCC), the immune landscape of ChRCC and its …

[HTML][HTML] Cost of bladder cancer in Lebanon before and after the economic collapse: a probabilistic modeling study

E Raad, S Helou, K Hage, M Daou… - International Journal for …, 2023 - Springer
Background and objectives Lebanon has one of the highest incidence rates of bladder
cancer (BC) in the world. In 2019, Lebanon’s economy collapsed which majorly impacted …

Development and evaluation of an electronic bladder cancer database in Beirut, Lebanon

K Hage, E Raad, M Daou, E El Helou - Journal of Health Informatics in …, 2023 - jhidc.org
Background: Bladder cancer very common in Lebanon. The use of electronic health records
has recently been correlated with improved medical record reconstruction, however studies …

[CITATION][C] Screening of ASS1 gene in seven families from Lebanon, Syria, Iraq, Kurdistan with citrullinemia type 1 identifies rare and novel variant

M Daou, M Souaid, T Yammine… - EUROPEAN …, 2022 - … , 4 CRINAN ST, LONDON, N1 9XW …